ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice
Kristen H. Schuster, Annie J. Zalon, Danielle M. DiFranco, Alexandra F. Putka, Nicholas R. Stec, Sabrina I. Jarrah, Arsal Naeem, Zaid Haque, Hanrui Zhang, Yuanfang Guan, Hayley S. McLoughlin
Topics & Concepts
DiseaseMedicineOligodendrocyteVirologyImmunologyInternal medicineMyelinCentral nervous systemNeurogenetic and Muscular Disorders ResearchNeurogenesis and neuroplasticity mechanismsRNA Research and Splicing